
Heron Therapeutics, Inc.: shareholders and insiders
Price
$0.26
November 19, 2026Market cap $50M
What Ploutos Investor adds for Heron Therapeutics
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from 2016
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 30% since Nov 9, 2026, when the 10-Q these figures come from was filed ($0.37 then, $0.26 on Nov 19, 2026). The figures date from before that move.10-Q
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors from Nov 20, 2025 to Nov 10, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
–
nobody
From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
No trades under these filters.
From the Form 4s insiders file with the SEC within two business days of each trade.
Insiders and their shares
Every buy and sale by HRTX's officers and directors from 2006 up to November 19, 2025, 20 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 15 more, back to 2006
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Rubric Capital Management LPwith 1 more personShare of class15.9%
- Clearline Capital LPwith 2 more personsShare of class6.70%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Rubric Capital Management LPwith 1 more person | 15.9% | 30.05M | Oct 17, 20252 filings since Aug 12, 2025 | 13D/A | |
| Clearline Capital LPwith 2 more persons | 6.70% | 12.24M | Feb 17, 20262 filings since Nov 26, 2025 | 13G/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Rubric Capital Management LP15.9%From the filing of Oct 17, 2025
On October 15, 2025, the Issuer filed a Current Report on Form 8-K with the SEC disclosing that it obtained Stockholder Approval, as a result of which, the 94,610 shares of Preferred Stock beneficially owned by the Reporting Persons automatically converted, without any action on the part of the holders thereof, into 946,100 Shares. Additionally, as previously disclosed, on August 8, 2025, a certain Rubric Fund entered into the Note Purchase Agreement with the Issuer, pursuant to which the Issuer issued and sold to such Rubric Fund $35,000,000 aggregate principal amount of Notes for an aggregate purchase price of $33,250,000. The Convertible Note Issuance provided for the issuance of Notes…
From the filing of Oct 17, 2025
Fell to 5% or less (2)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter
- Millennium Mgmt (Englander)In the quarter-64%
- D.E. ShawIn the quarter-32%
- Renaissance TechnologiesIn the quarter+4.1%
- AQR CapitalIn the quarter+28%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 477.2K | $100.0K | 0.00% | |
| Millennium Mgmt (Englander) | 1.46M | -64% | $500.0K | 0.00% |
| D.E. Shaw | 81.7K | -32% | $0 | 0.00% |
| Renaissance Technologies | 1.57M | +4.1% | $500.0K | 0.00% |
| AQR Capital | 1.99M | +28% | $600.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 19.5% of its shares outstanding were held short, -20.2% since the report before.
- Shares held short
- 36.74M
- 19.5%
- Since the report before46.02M on Sep 30, 2026
- -20.2%
- 14.2
- 2.58M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 98%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 18.41M
- Nov 15, 2023: Shares held short 17.59M
- Nov 30, 2023: Shares held short 21.58M
- Dec 15, 2023: Shares held short 21.00M
- Dec 29, 2023: Shares held short 20.21M
- Jan 12, 2024: Shares held short 21.52M
- Jan 31, 2024: Shares held short 24.33M
- Feb 15, 2024: Shares held short 24.62M
- Feb 29, 2024: Shares held short 24.53M
- Mar 15, 2024: Shares held short 25.43M
- Mar 28, 2024: Shares held short 25.55M
- Apr 15, 2024: Shares held short 25.43M
- Apr 30, 2024: Shares held short 27.29M
- May 15, 2024: Shares held short 30.27M
- May 31, 2024: Shares held short 30.04M
- Jun 14, 2024: Shares held short 30.47M
- Jun 28, 2024: Shares held short 32.82M
- Jul 15, 2024: Shares held short 35.66M
- Jul 31, 2024: Shares held short 35.63M
- Aug 15, 2024: Shares held short 35.96M
- Aug 30, 2024: Shares held short 35.92M
- Sep 13, 2024: Shares held short 35.44M
- Sep 30, 2024: Shares held short 31.70M
- Oct 15, 2024: Shares held short 30.64M
- Oct 31, 2024: Shares held short 28.81M
- Nov 15, 2024: Shares held short 27.91M
- Nov 29, 2024: Shares held short 27.54M
- Dec 13, 2024: Shares held short 29.98M
- Dec 31, 2024: Shares held short 30.71M
- Jan 15, 2025: Shares held short 31.06M
- Jan 31, 2025: Shares held short 30.84M
- Feb 14, 2025: Shares held short 30.77M
- Feb 28, 2025: Shares held short 31.33M
- Mar 14, 2025: Shares held short 32.07M
- Mar 31, 2025: Shares held short 32.52M
- Apr 15, 2025: Shares held short 32.96M
- Apr 30, 2025: Shares held short 33.30M
- May 15, 2025: Shares held short 34.41M
- May 30, 2025: Shares held short 33.96M
- Jun 13, 2025: Shares held short 34.21M
- Jun 30, 2025: Shares held short 36.92M
- Jul 15, 2025: Shares held short 35.32M
- Jul 31, 2025: Shares held short 35.26M
- Aug 15, 2025: Shares held short 33.23M
- Aug 29, 2025: Shares held short 32.39M
- Sep 15, 2025: Shares held short 32.96M
- Sep 30, 2025: Shares held short 34.38M
- Oct 15, 2025: Shares held short 32.90M
- Oct 31, 2025: Shares held short 34.87M
- Nov 14, 2025: Shares held short 36.59M
- Nov 28, 2025: Shares held short 35.97M
- Dec 15, 2025: Shares held short 33.10M
- Dec 31, 2025: Shares held short 34.05M
- Jan 15, 2026: Shares held short 35.49M
- Jan 30, 2026: Shares held short 35.26M
- Feb 13, 2026: Shares held short 35.36M
- Feb 27, 2026: Shares held short 37.13M
- Mar 13, 2026: Shares held short 36.83M
- Mar 31, 2026: Shares held short 39.42M
- Apr 15, 2026: Shares held short 41.15M
- Apr 30, 2026: Shares held short 40.88M
- May 15, 2026: Shares held short 39.68M
- May 29, 2026: Shares held short 40.16M
- Jun 15, 2026: Shares held short 41.88M
- Jun 30, 2026: Shares held short 40.50M
- Jul 15, 2026: Shares held short 42.63M
- Jul 31, 2026: Shares held short 43.24M
- Aug 14, 2026: Shares held short 46.74M
- Aug 31, 2026: Shares held short 44.86M
- Sep 15, 2026: Shares held short 43.38M
- Sep 30, 2026: Shares held short 46.02M
- Oct 15, 2026: Shares held short 36.74M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading39.1% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 39.1% of the shares in the reported trades were short sales, against 53.2% in the 14 before.
- Last 14 sessionsNov 2, 2026 – Nov 19, 2026
- 39.1%
- The 14 beforeOct 13, 2026 – Oct 30, 2026
- 53.2%
- Change
- -14.1 pts
- Short sales a dayon average, of 4.07M shares
- 1.59M
- More than atof 3,666 US-listed companies, same days
- 18%
- Median of alleight in ten from 34.5% to 63.8%
- 50.4%
- Short sales
- Oct 13, 2026: Short sales 65.2%
- Oct 14, 2026: Short sales 66.7%
- Oct 15, 2026: Short sales 38.8%
- Oct 16, 2026: Short sales 76.2%
- Oct 19, 2026: Short sales 52.8%
- Oct 20, 2026: Short sales 54.8%
- Oct 21, 2026: Short sales 55.2%
- Oct 22, 2026: Short sales 37.3%
- Oct 23, 2026: Short sales 62.2%
- Oct 26, 2026: Short sales 63.7%
- Oct 27, 2026: Short sales 34.9%
- Oct 28, 2026: Short sales 50.7%
- Oct 29, 2026: Short sales 49.2%
- Oct 30, 2026: Short sales 61.9%
- Nov 2, 2026: Short sales 57.7%
- Nov 3, 2026: Short sales 39%
- Nov 4, 2026: Short sales 29.3%
- Nov 5, 2026: Short sales 65.1%
- Nov 6, 2026: Short sales 47.1%
- Nov 9, 2026: Short sales 38.9%
- Nov 10, 2026: Short sales 38%
- Nov 11, 2026: Short sales 30.1%
- Nov 12, 2026: Short sales 61.9%
- Nov 13, 2026: Short sales 48.2%
- Nov 16, 2026: Short sales 21.3%
- Nov 17, 2026: Short sales 20.9%
- Nov 18, 2026: Short sales 38.7%
- Nov 19, 2026: Short sales 34.3%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Adam MorganDirectorDirectly–
- Craig A CollardChief Executive OfficerDirectly931.1K
- Ira DuarteEVP, Chief Financial OfficerDirectly302.7K
- William P ForbesEVP, Chief Development OfficerDirectly260.7K
- Mark Earl HensleyChief Operating OfficerDirectly201.7K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Adam MorganDirector | – | 8.75M | Aug 8, 2025 | Form 4 |
| Craig A CollardChief Executive Officer | 931.1K | – | Oct 31, 2026 | Form 4 |
| Ira DuarteEVP, Chief Financial Officer | 302.7K | – | Oct 31, 2026 | Form 4 |
| William P ForbesEVP, Chief Development Officer | 260.7K | – | Oct 31, 2026 | Form 4 |
| Mark Earl HensleyChief Operating Officer | 201.7K | – | Nov 6, 2026 | Form 4 |
A lower bound: it counts only the 5 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.02%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.00%
- IWMiShares Russell 2000 ETFWeight in the fund0.00%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.00%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.00%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.00%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- VHTVanguard Health Care Index FundWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
- ITOTiShares Core S&P Total U.S. Stock Market ETFWeight in the fund0.00%
11 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 172
- Q4 2025: Managers 170
- Q1 2026: Managers 168
- Q2 2026: Managers 162
Institutional investors by quarter
The fund managers holding HRTX, quarter by quarter, from Q1 2014 to Q2 2025, 46 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 162 managers held 134M shares, worth $57M. During the quarter 21 opened a position, 27 closed one, 57 added and 39 trimmed.
The largest holders, Q2 2026
- Rubric Capital ManagementIn the quarter
- Clearline CapitalIn the quarter-7.0%
- BlackRockIn the quarter+4.4%
- Velan Capital Investment ManagementIn the quarter
- Vanguard Capital ManagementIn the quarter-0.4%
- Tejara CapitalIn the quarter+2.7%
- Tang Capital ManagementIn the quarter
- Geode Capital ManagementIn the quarter+6.5%
- Millennium Mgmt (Englander)In the quarter-47%
- JW Asset ManagementIn the quarter
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Rubric Capital Management | 30.05M | $13M | |
| Clearline Capital | 11.38M | -7.0% | $4.9M |
| BlackRock | 10.55M | +4.4% | $4.5M |
| Velan Capital Investment Management | 8.75M | $3.7M | |
| Vanguard Capital Management | 7.78M | -0.4% | $3.3M |
| Tejara Capital | 6.51M | +2.7% | $2.8M |
| Tang Capital Management | 6.25M | $2.7M | |
| Geode Capital Management | 4.27M | +6.5% | $1.8M |
| Millennium Mgmt (Englander) | 4.07M | -47% | $1.7M |
| JW Asset Management | 3.75M | $1.6M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Heron Therapeutics's filings show?
Who buys and sells is one part of Heron Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have HRTX's insiders bought or sold?
From Jun 8, 2026 to Nov 10, 2026 Heron Therapeutics's insiders reported no purchase or sale of shares on the market.
Which well-known managers hold HRTX?
5 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $600.0K.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.